|Articles|March 1, 2012
- BioPharm International-03-01-2012
- Volume 25
- Issue 3
BioPharm International, March 2012 Issue (PDF)
Scale-Up of Human Stem Cells
Advertisement
Articles in this issue
over 13 years ago
Biosimilar Developers Face a Reference-Product Dilemmaover 13 years ago
Communications Advances Present Challenges to Manufacturersover 13 years ago
The Drive for Best Practice in Biopharmaceutical Manufacturingover 13 years ago
CMOs Face a Kodak Momentover 13 years ago
FDA Guides the Way to Biosimilars in the USover 13 years ago
Assessing Filling Technologies For Contamination Riskover 13 years ago
Putting Risk-Based Decision-Making Where It BelongsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement

